#FORMAT=WebAnno TSV 3.2
#T_SP=webanno.custom.Referent|entity|infstat
#T_RL=webanno.custom.Coref|type|BT_webanno.custom.Referent


#Text=2. Mutations Induced along with Genomic Destabilization
1-1	0-2	2.	abstract[1]	new[1]	coref	9-1[64_1]
1-2	3-12	Mutations	abstract[1]	new[1]	_	_
1-3	13-20	Induced	_	_	_	_
1-4	21-26	along	_	_	_	_
1-5	27-31	with	_	_	_	_
1-6	32-39	Genomic	abstract|event[3]	new|new[3]	coref|coref	12-14[100_3]|31-7
1-7	40-55	Destabilization	event[3]	new[3]	_	_

#Text=2.1 .
2-1	56-59	2.1	abstract	new	_	_
2-2	60-61	.	_	_	_	_

#Text=Mutation Rate and Its Association with Cancer Risk
3-1	62-70	Mutation	abstract|abstract[6]|abstract[7]	new|new[6]|new[7]	ana|coref|coref	3-4[0_6]|6-3|8-6[46_7]
3-2	71-75	Rate	abstract[6]|abstract[7]	new[6]|new[7]	_	_
3-3	76-79	and	abstract[7]	new[7]	_	_
3-4	80-83	Its	abstract[7]|abstract|abstract[9]	new[7]|giv|new[9]	coref	8-3[43_9]
3-5	84-95	Association	abstract[7]|abstract[9]	new[7]|new[9]	_	_
3-6	96-100	with	abstract[7]|abstract[9]	new[7]|new[9]	_	_
3-7	101-107	Cancer	abstract[7]|abstract[9]|abstract|abstract[11]	new[7]|new[9]|new|new[11]	coref|coref	7-15|7-27[42_11]
3-8	108-112	Risk	abstract[7]|abstract[9]|abstract[11]	new[7]|new[9]|new[11]	_	_

#Text=In normal human cells , DNA is usually replicated by high-fidelity polymerases δ and ε .
4-1	113-115	In	_	_	_	_
4-2	116-122	normal	object[12]	new[12]	ana	5-10[0_12]
4-3	123-128	human	object[12]	new[12]	_	_
4-4	129-134	cells	object[12]	new[12]	_	_
4-5	135-136	,	_	_	_	_
4-6	137-140	DNA	substance	new	_	_
4-7	141-143	is	_	_	_	_
4-8	144-151	usually	_	_	_	_
4-9	152-162	replicated	_	_	_	_
4-10	163-165	by	_	_	_	_
4-11	166-179	high-fidelity	abstract[15]|abstract[16]	new[15]|new[16]	coref	25-25[155_16]
4-12	180-191	polymerases	object|abstract[15]|abstract[16]	new|new[15]|new[16]	coref	5-4[19_0]
4-13	192-193	δ	abstract[15]|abstract[16]	new[15]|new[16]	_	_
4-14	194-197	and	abstract[16]	new[16]	_	_
4-15	198-199	ε	abstract[16]|abstract	new[16]|new	coref	7-8[35_0]
4-16	200-201	.	_	_	_	_

#Text=Errors caused by those polymerases are primarily repaired by their proofreading system ( Table 1 ) , and the remaining errors are targeted by the mismatch repair ( MMR ) system .
5-1	202-208	Errors	abstract	new	coref	5-19[24_0]
5-2	209-215	caused	_	_	_	_
5-3	216-218	by	_	_	_	_
5-4	219-224	those	object[19]	giv[19]	coref	24-22[146_19]
5-5	225-236	polymerases	object[19]	giv[19]	_	_
5-6	237-240	are	_	_	_	_
5-7	241-250	primarily	_	_	_	_
5-8	251-259	repaired	_	_	_	_
5-9	260-262	by	_	_	_	_
5-10	263-268	their	object|abstract[22]	giv|new[22]	coref|coref	5-31[0_22]|8-45
5-11	269-281	proofreading	organization|abstract[22]	new|new[22]	coref	7-5
5-12	282-288	system	abstract[22]	new[22]	_	_
5-13	289-290	(	_	_	_	_
5-14	291-296	Table	object[23]	new[23]	coref	24-26[147_23]
5-15	297-298	1	object[23]	new[23]	_	_
5-16	299-300	)	_	_	_	_
5-17	301-302	,	_	_	_	_
5-18	303-306	and	_	_	_	_
5-19	307-310	the	abstract[24]	giv[24]	coref	17-16[0_24]
5-20	311-320	remaining	abstract[24]	giv[24]	_	_
5-21	321-327	errors	abstract[24]	giv[24]	_	_
5-22	328-331	are	_	_	_	_
5-23	332-340	targeted	_	_	_	_
5-24	341-343	by	_	_	_	_
5-25	344-347	the	abstract[26]	new[26]	appos	5-29[0_26]
5-26	348-356	mismatch	abstract|abstract[26]	new|new[26]	_	_
5-27	357-363	repair	abstract[26]	new[26]	_	_
5-28	364-365	(	_	_	_	_
5-29	366-369	MMR	abstract	giv	coref	7-3
5-30	370-371	)	_	_	_	_
5-31	372-378	system	abstract	giv	_	_
5-32	379-380	.	_	_	_	_

#Text=Consequently , mutation is largely suppressed during normal replication .
6-1	381-393	Consequently	_	_	_	_
6-2	394-395	,	_	_	_	_
6-3	396-404	mutation	abstract	giv	coref	7-21
6-4	405-407	is	_	_	_	_
6-5	408-415	largely	_	_	_	_
6-6	416-426	suppressed	_	_	_	_
6-7	427-433	during	_	_	_	_
6-8	434-440	normal	abstract[30]	new[30]	coref	11-26[0_30]
6-9	441-452	replication	abstract[30]	new[30]	_	_
6-10	453-454	.	_	_	_	_

#Text=Deficiencies in MMR and proofreading performed by polymerase ε are associated with hypermutation and cancer predisposition ; thus , the mutation rate is strongly associated with cancer risk .
7-1	455-467	Deficiencies	abstract	new	_	_
7-2	468-470	in	_	_	_	_
7-3	471-474	MMR	abstract	giv	coref	24-19
7-4	475-478	and	_	_	_	_
7-5	479-491	proofreading	event	giv	coref	27-20
7-6	492-501	performed	_	_	_	_
7-7	502-504	by	_	_	_	_
7-8	505-515	polymerase	object|abstract[35]	new|giv[35]	coref	25-27[0_35]
7-9	516-517	ε	abstract[35]	giv[35]	_	_
7-10	518-521	are	_	_	_	_
7-11	522-532	associated	_	_	_	_
7-12	533-537	with	_	_	_	_
7-13	538-551	hypermutation	event|abstract[38]	new|new[38]	coref	12-10
7-14	552-555	and	abstract[38]	new[38]	_	_
7-15	556-562	cancer	abstract|abstract[38]	giv|new[38]	coref	7-27
7-16	563-577	predisposition	abstract[38]	new[38]	_	_
7-17	578-579	;	_	_	_	_
7-18	580-584	thus	_	_	_	_
7-19	585-586	,	_	_	_	_
7-20	587-590	the	abstract[40]	new[40]	coref	8-6[45_40]
7-21	591-599	mutation	abstract|abstract[40]	giv|new[40]	coref	8-6
7-22	600-604	rate	abstract[40]	new[40]	_	_
7-23	605-607	is	_	_	_	_
7-24	608-616	strongly	_	_	_	_
7-25	617-627	associated	_	_	_	_
7-26	628-632	with	_	_	_	_
7-27	633-639	cancer	abstract|event[42]	giv|giv[42]	coref|coref	8-9|8-9[48_42]
7-28	640-644	risk	event[42]	giv[42]	_	_
7-29	645-646	.	_	_	_	_

#Text=However , this association between mutation rate and cancer risk may be unrelated to cell division frequency and resultant changes in cell number , as aptly pointed out by Peto ’s paradox : cancer incidence does not appear to correlate with the number of cells in an organism at the species level .
8-1	647-654	However	_	_	_	_
8-2	655-656	,	_	_	_	_
8-3	657-661	this	abstract[43]	giv[43]	coref	16-30[114_43]
8-4	662-673	association	abstract[43]	giv[43]	_	_
8-5	674-681	between	abstract[43]	giv[43]	_	_
8-6	682-690	mutation	abstract[43]|abstract|abstract[45]|abstract[46]	giv[43]|giv|giv[45]|giv[46]	coref	10-12
8-7	691-695	rate	abstract[43]|abstract[45]|abstract[46]	giv[43]|giv[45]|giv[46]	_	_
8-8	696-699	and	abstract[43]|abstract[46]	giv[43]|giv[46]	_	_
8-9	700-706	cancer	abstract[43]|abstract[46]|abstract|abstract[48]	giv[43]|giv[46]|giv|giv[48]	coref|coref	8-34|31-4[190_48]
8-10	707-711	risk	abstract[43]|abstract[46]|abstract[48]	giv[43]|giv[46]|giv[48]	_	_
8-11	712-715	may	_	_	_	_
8-12	716-718	be	_	_	_	_
8-13	719-728	unrelated	_	_	_	_
8-14	729-731	to	_	_	_	_
8-15	732-736	cell	place|event[51]	new|new[51]	coref	8-22
8-16	737-745	division	abstract|event[51]	new|new[51]	coref	28-9[177_0]
8-17	746-755	frequency	event[51]	new[51]	_	_
8-18	756-759	and	_	_	_	_
8-19	760-769	resultant	abstract[52]	new[52]	_	_
8-20	770-777	changes	abstract[52]	new[52]	_	_
8-21	778-780	in	abstract[52]	new[52]	_	_
8-22	781-785	cell	abstract[52]|object|quantity[54]	new[52]|giv|new[54]	coref|coref	8-42[59_54]|28-10
8-23	786-792	number	abstract[52]|quantity[54]	new[52]|new[54]	_	_
8-24	793-794	,	_	_	_	_
8-25	795-797	as	_	_	_	_
8-26	798-803	aptly	_	_	_	_
8-27	804-811	pointed	_	_	_	_
8-28	812-815	out	_	_	_	_
8-29	816-818	by	_	_	_	_
8-30	819-823	Peto	person[55]|abstract[56]	new[55]|new[56]	_	_
8-31	824-826	’s	person[55]|abstract[56]	new[55]|new[56]	_	_
8-32	827-834	paradox	abstract[56]	new[56]	_	_
8-33	835-836	:	_	_	_	_
8-34	837-843	cancer	abstract|abstract[58]	giv|new[58]	coref	9-3
8-35	844-853	incidence	abstract[58]	new[58]	_	_
8-36	854-858	does	_	_	_	_
8-37	859-862	not	_	_	_	_
8-38	863-869	appear	_	_	_	_
8-39	870-872	to	_	_	_	_
8-40	873-882	correlate	_	_	_	_
8-41	883-887	with	_	_	_	_
8-42	888-891	the	quantity[59]	giv[59]	_	_
8-43	892-898	number	quantity[59]	giv[59]	_	_
8-44	899-901	of	quantity[59]	giv[59]	_	_
8-45	902-907	cells	quantity[59]|object	giv[59]|giv	coref	9-3[66_0]
8-46	908-910	in	_	_	_	_
8-47	911-913	an	animal[61]	new[61]	_	_
8-48	914-922	organism	animal[61]	new[61]	_	_
8-49	923-925	at	animal[61]	new[61]	_	_
8-50	926-929	the	animal[61]|abstract[63]	new[61]|new[63]	_	_
8-51	930-937	species	animal[61]|person|abstract[63]	new[61]|new|new[63]	_	_
8-52	938-943	level	animal[61]|abstract[63]	new[61]|new[63]	_	_
8-53	944-945	.	_	_	_	_

#Text=Mutations in cancer cells are not induced randomly .
9-1	946-955	Mutations	abstract[64]	giv[64]	coref	15-2[106_64]
9-2	956-958	in	abstract[64]	giv[64]	_	_
9-3	959-965	cancer	abstract[64]|abstract|object[66]	giv[64]|giv|giv[66]	coref|coref	15-7|15-7[108_66]
9-4	966-971	cells	abstract[64]|object[66]	giv[64]|giv[66]	_	_
9-5	972-975	are	_	_	_	_
9-6	976-979	not	_	_	_	_
9-7	980-987	induced	_	_	_	_
9-8	988-996	randomly	_	_	_	_
9-9	997-998	.	_	_	_	_

#Text=Based on whole-genome and exome analyses , chromatin loci with higher mutation levels can be characterized as ( I ) gene loci that are not highly expressed , ( II ) chromosome regions replicating in late S phase , ( III ) heterochromatic loci , and ( IV ) loci with closed chromatin that is not sensitive to DNase I. Mutation rates differ by severalfold between high- and low-mutation loci .
10-1	999-1004	Based	_	_	_	_
10-2	1005-1007	on	_	_	_	_
10-3	1008-1020	whole-genome	abstract	new	_	_
10-4	1021-1024	and	_	_	_	_
10-5	1025-1030	exome	abstract|abstract[69]	new|new[69]	_	_
10-6	1031-1039	analyses	abstract[69]	new[69]	_	_
10-7	1040-1041	,	_	_	_	_
10-8	1042-1051	chromatin	substance|object[71]	new|new[71]	coref|coref	10-43[79_71]|10-52[81_0]
10-9	1052-1056	loci	object[71]	new[71]	_	_
10-10	1057-1061	with	object[71]	new[71]	_	_
10-11	1062-1068	higher	object[71]|abstract[73]	new[71]|new[73]	_	_
10-12	1069-1077	mutation	object[71]|abstract|abstract[73]	new[71]|giv|new[73]	coref	10-61
10-13	1078-1084	levels	object[71]|abstract[73]	new[71]|new[73]	_	_
10-14	1085-1088	can	_	_	_	_
10-15	1089-1091	be	_	_	_	_
10-16	1092-1105	characterized	_	_	_	_
10-17	1106-1108	as	_	_	_	_
10-18	1109-1110	(	_	_	_	_
10-19	1111-1112	I	abstract	new	_	_
10-20	1113-1114	)	_	_	_	_
10-21	1115-1119	gene	abstract	new	_	_
10-22	1120-1124	loci	_	_	_	_
10-23	1125-1129	that	_	_	_	_
10-24	1130-1133	are	_	_	_	_
10-25	1134-1137	not	_	_	_	_
10-26	1138-1144	highly	_	_	_	_
10-27	1145-1154	expressed	_	_	_	_
10-28	1155-1156	,	_	_	_	_
10-29	1157-1158	(	_	_	_	_
10-30	1159-1161	II	_	_	_	_
10-31	1162-1163	)	_	_	_	_
10-32	1164-1174	chromosome	place	new	_	_
10-33	1175-1182	regions	_	_	_	_
10-34	1183-1194	replicating	_	_	_	_
10-35	1195-1197	in	_	_	_	_
10-36	1198-1202	late	time[77]	new[77]	_	_
10-37	1203-1204	S	time[77]	new[77]	_	_
10-38	1205-1210	phase	time[77]	new[77]	_	_
10-39	1211-1212	,	_	_	_	_
10-40	1213-1214	(	_	_	_	_
10-41	1215-1218	III	person	new	_	_
10-42	1219-1220	)	_	_	_	_
10-43	1221-1236	heterochromatic	object[79]	giv[79]	coref	10-67[87_79]
10-44	1237-1241	loci	object[79]	giv[79]	_	_
10-45	1242-1243	,	object[79]	giv[79]	_	_
10-46	1244-1247	and	object[79]	giv[79]	_	_
10-47	1248-1249	(	object[79]	giv[79]	_	_
10-48	1250-1252	IV	object[79]|person	giv[79]|new	_	_
10-49	1253-1254	)	object[79]	giv[79]	_	_
10-50	1255-1259	loci	object[79]	giv[79]	_	_
10-51	1260-1264	with	_	_	_	_
10-52	1265-1271	closed	substance[81]	giv[81]	_	_
10-53	1272-1281	chromatin	substance[81]	giv[81]	_	_
10-54	1282-1286	that	_	_	_	_
10-55	1287-1289	is	_	_	_	_
10-56	1290-1293	not	_	_	_	_
10-57	1294-1303	sensitive	_	_	_	_
10-58	1304-1306	to	_	_	_	_
10-59	1307-1312	DNase	object|quantity[85]	new|new[85]	coref	27-3[166_85]
10-60	1313-1315	I.	person|quantity[85]	new|new[85]	_	_
10-61	1316-1324	Mutation	abstract|quantity[85]	giv|new[85]	coref	14-1
10-62	1325-1330	rates	quantity[85]	new[85]	_	_
10-63	1331-1337	differ	_	_	_	_
10-64	1338-1340	by	_	_	_	_
10-65	1341-1352	severalfold	_	_	_	_
10-66	1353-1360	between	_	_	_	_
10-67	1361-1366	high-	abstract|object[87]	new|giv[87]	coref	11-20[92_87]
10-68	1367-1370	and	object[87]	giv[87]	_	_
10-69	1371-1383	low-mutation	object[87]	giv[87]	_	_
10-70	1384-1388	loci	object[87]	giv[87]	_	_
10-71	1389-1390	.	_	_	_	_

#Text=Although the source of these differences remains unclear , the phenomenon might be associated with genomic instability , as heterochromatic loci are often subjected to replication stress and chromosomal rearrangements .
11-1	1391-1399	Although	_	_	_	_
11-2	1400-1403	the	abstract[88]	new[88]	_	_
11-3	1404-1410	source	abstract[88]	new[88]	_	_
11-4	1411-1413	of	abstract[88]	new[88]	_	_
11-5	1414-1419	these	abstract[88]|abstract[89]	new[88]|new[89]	_	_
11-6	1420-1431	differences	abstract[88]|abstract[89]	new[88]|new[89]	_	_
11-7	1432-1439	remains	_	_	_	_
11-8	1440-1447	unclear	_	_	_	_
11-9	1448-1449	,	_	_	_	_
11-10	1450-1453	the	abstract[90]	new[90]	_	_
11-11	1454-1464	phenomenon	abstract[90]	new[90]	_	_
11-12	1465-1470	might	_	_	_	_
11-13	1471-1473	be	_	_	_	_
11-14	1474-1484	associated	_	_	_	_
11-15	1485-1489	with	_	_	_	_
11-16	1490-1497	genomic	abstract[91]	new[91]	coref	29-7[183_91]
11-17	1498-1509	instability	abstract[91]	new[91]	_	_
11-18	1510-1511	,	_	_	_	_
11-19	1512-1514	as	_	_	_	_
11-20	1515-1530	heterochromatic	object[92]	giv[92]	_	_
11-21	1531-1535	loci	object[92]	giv[92]	_	_
11-22	1536-1539	are	_	_	_	_
11-23	1540-1545	often	_	_	_	_
11-24	1546-1555	subjected	_	_	_	_
11-25	1556-1558	to	_	_	_	_
11-26	1559-1570	replication	abstract|abstract[94]	giv|new[94]	ana|coref	12-3[0_94]|16-23[113_0]
11-27	1571-1577	stress	abstract[94]	new[94]	_	_
11-28	1578-1581	and	_	_	_	_
11-29	1582-1593	chromosomal	animal|abstract[96]	new|new[96]	_	_
11-30	1594-1608	rearrangements	abstract[96]	new[96]	_	_
11-31	1609-1610	.	_	_	_	_

#Text=Consistent with this , a recent study reported that hypermutation is associated with genomic destabilization .
12-1	1611-1621	Consistent	_	_	_	_
12-2	1622-1626	with	_	_	_	_
12-3	1627-1631	this	abstract	giv	_	_
12-4	1632-1633	,	_	_	_	_
12-5	1634-1635	a	event[98]	new[98]	coref	16-3[110_98]
12-6	1636-1642	recent	event[98]	new[98]	_	_
12-7	1643-1648	study	event[98]	new[98]	_	_
12-8	1649-1657	reported	_	_	_	_
12-9	1658-1662	that	_	_	_	_
12-10	1663-1676	hypermutation	event	giv	coref	18-8
12-11	1677-1679	is	_	_	_	_
12-12	1680-1690	associated	_	_	_	_
12-13	1691-1695	with	_	_	_	_
12-14	1696-1703	genomic	abstract[100]	giv[100]	coref	16-39[117_100]
12-15	1704-1719	destabilization	abstract[100]	giv[100]	_	_
12-16	1720-1721	.	_	_	_	_

#Text=2.2 .
13-1	1722-1725	2.2	abstract	new	_	_
13-2	1726-1727	.	_	_	_	_

#Text=Mutation Induction when Replication-Stress-Associated DSBs Accumulate
14-1	1728-1736	Mutation	abstract|abstract[103]	giv|new[103]	coref|coref	27-5|34-1[207_103]
14-2	1737-1746	Induction	abstract[103]	new[103]	_	_
14-3	1747-1751	when	_	_	_	_
14-4	1752-1781	Replication-Stress-Associated	abstract|abstract[105]	new|new[105]	coref	16-32[115_105]
14-5	1782-1786	DSBs	abstract[105]	new[105]	_	_
14-6	1787-1797	Accumulate	_	_	_	_

#Text=Among the many mutations induced in cancer cells , somatically-induced replicative mutations are the most prominent .
15-1	1798-1803	Among	_	_	_	_
15-2	1804-1807	the	abstract[106]	giv[106]	coref	15-10[109_106]
15-3	1808-1812	many	abstract[106]	giv[106]	_	_
15-4	1813-1822	mutations	abstract[106]	giv[106]	_	_
15-5	1823-1830	induced	_	_	_	_
15-6	1831-1833	in	_	_	_	_
15-7	1834-1840	cancer	abstract|object[108]	giv|giv[108]	coref|coref	17-9[120_108]|29-20
15-8	1841-1846	cells	object[108]	giv[108]	_	_
15-9	1847-1848	,	_	_	_	_
15-10	1849-1868	somatically-induced	abstract[109]	giv[109]	coref	16-7[111_109]
15-11	1869-1880	replicative	abstract[109]	giv[109]	_	_
15-12	1881-1890	mutations	abstract[109]	giv[109]	_	_
15-13	1891-1894	are	_	_	_	_
15-14	1895-1898	the	_	_	_	_
15-15	1899-1903	most	_	_	_	_
15-16	1904-1913	prominent	_	_	_	_
15-17	1914-1915	.	_	_	_	_

#Text=Based on a recent study , such replicative mutations can be separated into two types : those induced as random errors during canonical replication , and those induced in association with replication-stress-associated DSBs that accumulate in association with genomic destabilization .
16-1	1916-1921	Based	_	_	_	_
16-2	1922-1924	on	_	_	_	_
16-3	1925-1926	a	abstract[110]	giv[110]	_	_
16-4	1927-1933	recent	abstract[110]	giv[110]	_	_
16-5	1934-1939	study	abstract[110]	giv[110]	_	_
16-6	1940-1941	,	_	_	_	_
16-7	1942-1946	such	abstract[111]	giv[111]	coref	21-3[131_111]
16-8	1947-1958	replicative	abstract[111]	giv[111]	_	_
16-9	1959-1968	mutations	abstract[111]	giv[111]	_	_
16-10	1969-1972	can	_	_	_	_
16-11	1973-1975	be	_	_	_	_
16-12	1976-1985	separated	_	_	_	_
16-13	1986-1990	into	_	_	_	_
16-14	1991-1994	two	abstract[112]	new[112]	_	_
16-15	1995-2000	types	abstract[112]	new[112]	_	_
16-16	2001-2002	:	_	_	_	_
16-17	2003-2008	those	_	_	_	_
16-18	2009-2016	induced	_	_	_	_
16-19	2017-2019	as	_	_	_	_
16-20	2020-2026	random	_	_	_	_
16-21	2027-2033	errors	_	_	_	_
16-22	2034-2040	during	_	_	_	_
16-23	2041-2050	canonical	abstract[113]	giv[113]	coref	17-18[0_113]
16-24	2051-2062	replication	abstract[113]	giv[113]	_	_
16-25	2063-2064	,	_	_	_	_
16-26	2065-2068	and	_	_	_	_
16-27	2069-2074	those	_	_	_	_
16-28	2075-2082	induced	_	_	_	_
16-29	2083-2085	in	_	_	_	_
16-30	2086-2097	association	abstract[114]	giv[114]	coref	16-37[116_114]
16-31	2098-2102	with	abstract[114]	giv[114]	_	_
16-32	2103-2132	replication-stress-associated	abstract[114]|abstract[115]	giv[114]|giv[115]	coref	18-13[0_115]
16-33	2133-2137	DSBs	abstract[114]|abstract[115]	giv[114]|giv[115]	_	_
16-34	2138-2142	that	_	_	_	_
16-35	2143-2153	accumulate	_	_	_	_
16-36	2154-2156	in	_	_	_	_
16-37	2157-2168	association	abstract[116]	giv[116]	coref	18-11[125_116]
16-38	2169-2173	with	abstract[116]	giv[116]	_	_
16-39	2174-2181	genomic	abstract[116]|abstract[117]	giv[116]|giv[117]	coref	18-15[128_117]
16-40	2182-2197	destabilization	abstract[116]|abstract[117]	giv[116]|giv[117]	_	_
16-41	2198-2199	.	_	_	_	_

#Text=Unexpectedly , the former type is relatively rare even in MMR-deficient cells that cannot correct errors during replication .
17-1	2200-2212	Unexpectedly	_	_	_	_
17-2	2213-2214	,	_	_	_	_
17-3	2215-2218	the	abstract[118]	new[118]	_	_
17-4	2219-2225	former	abstract[118]	new[118]	_	_
17-5	2226-2230	type	abstract[118]	new[118]	_	_
17-6	2231-2233	is	_	_	_	_
17-7	2234-2244	relatively	_	_	_	_
17-8	2245-2249	rare	_	_	_	_
17-9	2250-2254	even	object[120]	giv[120]	coref	18-20[0_120]
17-10	2255-2257	in	object[120]	giv[120]	_	_
17-11	2258-2271	MMR-deficient	person|object[120]	new|giv[120]	coref	33-12
17-12	2272-2277	cells	object[120]	giv[120]	_	_
17-13	2278-2282	that	_	_	_	_
17-14	2283-2289	cannot	_	_	_	_
17-15	2290-2297	correct	_	_	_	_
17-16	2298-2304	errors	abstract	giv	coref	27-24[172_0]
17-17	2305-2311	during	_	_	_	_
17-18	2312-2323	replication	abstract	giv	coref	37-21
17-19	2324-2325	.	_	_	_	_

#Text=By contrast , in the latter , hypermutation occurs in association with DSBs and genomic destabilization in barely replicating cells (
18-1	2326-2328	By	_	_	_	_
18-2	2329-2337	contrast	abstract	new	_	_
18-3	2338-2339	,	_	_	_	_
18-4	2340-2342	in	_	_	_	_
18-5	2343-2346	the	_	_	_	_
18-6	2347-2353	latter	_	_	_	_
18-7	2354-2355	,	_	_	_	_
18-8	2356-2369	hypermutation	abstract	giv	_	_
18-9	2370-2376	occurs	_	_	_	_
18-10	2377-2379	in	_	_	_	_
18-11	2380-2391	association	abstract[125]	giv[125]	_	_
18-12	2392-2396	with	abstract[125]	giv[125]	_	_
18-13	2397-2401	DSBs	abstract[125]|abstract|abstract[127]	giv[125]|giv|new[127]	coref|coref	25-3[148_127]|34-11[210_0]
18-14	2402-2405	and	abstract[125]|abstract[127]	giv[125]|new[127]	_	_
18-15	2406-2413	genomic	abstract[125]|abstract[127]|abstract[128]	giv[125]|new[127]|giv[128]	coref	28-20[181_128]
18-16	2414-2429	destabilization	abstract[125]|abstract[127]|abstract[128]	giv[125]|new[127]|giv[128]	_	_
18-17	2430-2432	in	_	_	_	_
18-18	2433-2439	barely	_	_	_	_
18-19	2440-2451	replicating	_	_	_	_
18-20	2452-2457	cells	object	giv	coref	32-1[194_0]
18-21	2458-2459	(	_	_	_	_

#Text=Figure 1
19-1	2460-2466	Figure	object[130]	new[130]	coref	22-1[139_130]
19-2	2467-2468	1	object[130]	new[130]	_	_

#Text=) .
20-1	2469-2470	)	_	_	_	_
20-2	2471-2472	.	_	_	_	_

#Text=Importantly , cancer-driver mutations arise during the latter ; the induced mutations include base substitutions , small insertions and deletions , and large deletions of entire genes (
21-1	2473-2484	Importantly	_	_	_	_
21-2	2485-2486	,	_	_	_	_
21-3	2487-2500	cancer-driver	abstract[131]	giv[131]	coref	21-10[132_131]
21-4	2501-2510	mutations	abstract[131]	giv[131]	_	_
21-5	2511-2516	arise	_	_	_	_
21-6	2517-2523	during	_	_	_	_
21-7	2524-2527	the	_	_	_	_
21-8	2528-2534	latter	_	_	_	_
21-9	2535-2536	;	_	_	_	_
21-10	2537-2540	the	abstract[132]	giv[132]	coref	24-5[141_132]
21-11	2541-2548	induced	abstract[132]	giv[132]	_	_
21-12	2549-2558	mutations	abstract[132]	giv[132]	_	_
21-13	2559-2566	include	_	_	_	_
21-14	2567-2571	base	place|abstract[134]	new|new[134]	_	_
21-15	2572-2585	substitutions	abstract[134]	new[134]	_	_
21-16	2586-2587	,	_	_	_	_
21-17	2588-2593	small	abstract[135]	new[135]	_	_
21-18	2594-2604	insertions	abstract[135]	new[135]	_	_
21-19	2605-2608	and	_	_	_	_
21-20	2609-2618	deletions	event	new	_	_
21-21	2619-2620	,	_	_	_	_
21-22	2621-2624	and	_	_	_	_
21-23	2625-2630	large	abstract[137]	new[137]	coref	38-36[0_137]
21-24	2631-2640	deletions	abstract[137]	new[137]	_	_
21-25	2641-2643	of	abstract[137]	new[137]	_	_
21-26	2644-2650	entire	abstract[137]|abstract[138]	new[137]|new[138]	_	_
21-27	2651-2656	genes	abstract[137]|abstract[138]	new[137]|new[138]	_	_
21-28	2657-2658	(	_	_	_	_

#Text=Figure 1
22-1	2659-2665	Figure	object[139]	giv[139]	_	_
22-2	2666-2667	1	object[139]	giv[139]	_	_

#Text=) .
23-1	2668-2669	)	_	_	_	_
23-2	2670-2671	.	_	_	_	_

#Text=The mechanisms responsible for mutations in this context are not clear , probably because of the presence of repair systems and other related polymerases ( Table 1 ) .
24-1	2672-2675	The	abstract[140]	new[140]	_	_
24-2	2676-2686	mechanisms	abstract[140]	new[140]	_	_
24-3	2687-2698	responsible	abstract[140]	new[140]	_	_
24-4	2699-2702	for	_	_	_	_
24-5	2703-2712	mutations	abstract[141]	giv[141]	coref	28-4[0_141]
24-6	2713-2715	in	abstract[141]	giv[141]	_	_
24-7	2716-2720	this	abstract[141]|abstract[142]	giv[141]|new[142]	_	_
24-8	2721-2728	context	abstract[141]|abstract[142]	giv[141]|new[142]	_	_
24-9	2729-2732	are	_	_	_	_
24-10	2733-2736	not	_	_	_	_
24-11	2737-2742	clear	_	_	_	_
24-12	2743-2744	,	_	_	_	_
24-13	2745-2753	probably	_	_	_	_
24-14	2754-2761	because	_	_	_	_
24-15	2762-2764	of	_	_	_	_
24-16	2765-2768	the	abstract[143]	new[143]	_	_
24-17	2769-2777	presence	abstract[143]	new[143]	_	_
24-18	2778-2780	of	abstract[143]	new[143]	_	_
24-19	2781-2787	repair	abstract[143]|abstract|abstract[145]	new[143]|giv|new[145]	coref	41-10[238_0]
24-20	2788-2795	systems	abstract[143]|abstract[145]	new[143]|new[145]	_	_
24-21	2796-2799	and	abstract[143]	new[143]	_	_
24-22	2800-2805	other	abstract[143]|object[146]	new[143]|giv[146]	coref	25-20[152_146]
24-23	2806-2813	related	abstract[143]|object[146]	new[143]|giv[146]	_	_
24-24	2814-2825	polymerases	abstract[143]|object[146]	new[143]|giv[146]	_	_
24-25	2826-2827	(	_	_	_	_
24-26	2828-2833	Table	object[147]	giv[147]	coref	33-15[206_147]
24-27	2834-2835	1	object[147]	giv[147]	_	_
24-28	2836-2837	)	_	_	_	_
24-29	2838-2839	.	_	_	_	_

#Text=Indeed , these DSBs are generally a target of homologous recombination ( HR ) , which does not involve high-fidelity polymerases ( pols ) δ and ε .
25-1	2840-2846	Indeed	_	_	_	_
25-2	2847-2848	,	_	_	_	_
25-3	2849-2854	these	abstract[148]	giv[148]	coref	25-6[149_148]
25-4	2855-2859	DSBs	abstract[148]	giv[148]	_	_
25-5	2860-2863	are	_	_	_	_
25-6	2864-2873	generally	abstract[149]	giv[149]	coref	37-5[213_149]
25-7	2874-2875	a	abstract[149]	giv[149]	_	_
25-8	2876-2882	target	abstract[149]	giv[149]	_	_
25-9	2883-2885	of	abstract[149]	giv[149]	_	_
25-10	2886-2896	homologous	abstract[149]|abstract[150]	giv[149]|new[150]	appos	25-13[0_150]
25-11	2897-2910	recombination	abstract[149]|abstract[150]	giv[149]|new[150]	_	_
25-12	2911-2912	(	_	_	_	_
25-13	2913-2915	HR	abstract	giv	coref	37-12
25-14	2916-2917	)	_	_	_	_
25-15	2918-2919	,	_	_	_	_
25-16	2920-2925	which	_	_	_	_
25-17	2926-2930	does	_	_	_	_
25-18	2931-2934	not	_	_	_	_
25-19	2935-2942	involve	_	_	_	_
25-20	2943-2956	high-fidelity	object[152]	giv[152]	coref	27-15[169_152]
25-21	2957-2968	polymerases	object[152]	giv[152]	_	_
25-22	2969-2970	(	_	_	_	_
25-23	2971-2975	pols	abstract	new	_	_
25-24	2976-2977	)	_	_	_	_
25-25	2978-2979	δ	abstract|abstract[155]	new|giv[155]	coref	26-10
25-26	2980-2983	and	abstract[155]	giv[155]	_	_
25-27	2984-2985	ε	abstract[155]|abstract	giv[155]|giv	_	_
25-28	2986-2987	.	_	_	_	_

#Text=Instead , low-fidelity translesion synthesis ( TLS ) polymerases δ , κ , and θ , which synthesize DNA over lesioned templates , are highly expressed .
26-1	2988-2995	Instead	_	_	_	_
26-2	2996-2997	,	_	_	_	_
26-3	2998-3010	low-fidelity	abstract[158]	new[158]	appos	26-7[0_158]
26-4	3011-3022	translesion	abstract|abstract[158]	new|new[158]	coref	27-29
26-5	3023-3032	synthesis	abstract[158]	new[158]	_	_
26-6	3033-3034	(	_	_	_	_
26-7	3035-3038	TLS	abstract	giv	coref	27-11[168_0]
26-8	3039-3040	)	_	_	_	_
26-9	3041-3052	polymerases	_	_	_	_
26-10	3053-3054	δ	abstract	giv	_	_
26-11	3055-3056	,	_	_	_	_
26-12	3057-3058	κ	abstract	new	_	_
26-13	3059-3060	,	_	_	_	_
26-14	3061-3064	and	_	_	_	_
26-15	3065-3066	θ	abstract	new	_	_
26-16	3067-3068	,	_	_	_	_
26-17	3069-3074	which	_	_	_	_
26-18	3075-3085	synthesize	_	_	_	_
26-19	3086-3089	DNA	abstract	new	coref	27-11
26-20	3090-3094	over	_	_	_	_
26-21	3095-3103	lesioned	object[164]	new[164]	_	_
26-22	3104-3113	templates	object[164]	new[164]	_	_
26-23	3114-3115	,	_	_	_	_
26-24	3116-3119	are	_	_	_	_
26-25	3120-3126	highly	_	_	_	_
26-26	3127-3136	expressed	_	_	_	_
26-27	3137-3138	.	_	_	_	_

#Text=Thus , the higher mutation rates are probably due to DNA synthesis performed by these polymerases , which lack proofreading activity , and the errors probably occur during translesion synthesis .
27-1	3139-3143	Thus	_	_	_	_
27-2	3144-3145	,	_	_	_	_
27-3	3146-3149	the	quantity[166]	giv[166]	_	_
27-4	3150-3156	higher	quantity[166]	giv[166]	_	_
27-5	3157-3165	mutation	abstract|quantity[166]	giv|giv[166]	_	_
27-6	3166-3171	rates	quantity[166]	giv[166]	_	_
27-7	3172-3175	are	_	_	_	_
27-8	3176-3184	probably	_	_	_	_
27-9	3185-3188	due	_	_	_	_
27-10	3189-3191	to	_	_	_	_
27-11	3192-3195	DNA	abstract|abstract[168]	giv|giv[168]	coref|coref	27-29[174_168]|45-22
27-12	3196-3205	synthesis	abstract[168]	giv[168]	_	_
27-13	3206-3215	performed	_	_	_	_
27-14	3216-3218	by	_	_	_	_
27-15	3219-3224	these	object[169]	giv[169]	ana	28-13[0_169]
27-16	3225-3236	polymerases	object[169]	giv[169]	_	_
27-17	3237-3238	,	_	_	_	_
27-18	3239-3244	which	_	_	_	_
27-19	3245-3249	lack	_	_	_	_
27-20	3250-3262	proofreading	object|abstract[171]	giv|new[171]	_	_
27-21	3263-3271	activity	abstract[171]	new[171]	_	_
27-22	3272-3273	,	_	_	_	_
27-23	3274-3277	and	_	_	_	_
27-24	3278-3281	the	abstract[172]	giv[172]	_	_
27-25	3282-3288	errors	abstract[172]	giv[172]	_	_
27-26	3289-3297	probably	_	_	_	_
27-27	3298-3303	occur	_	_	_	_
27-28	3304-3310	during	_	_	_	_
27-29	3311-3322	translesion	abstract|abstract[174]	giv|giv[174]	_	_
27-30	3323-3332	synthesis	abstract[174]	giv[174]	_	_
27-31	3333-3334	.	_	_	_	_

#Text=Thus , while mutations are strongly suppressed during normal cell division , they increase after replication-stress-associated DSB accumulation and genomic destabilization .
28-1	3335-3339	Thus	_	_	_	_
28-2	3340-3341	,	_	_	_	_
28-3	3342-3347	while	_	_	_	_
28-4	3348-3357	mutations	abstract	giv	coref	29-10[184_0]
28-5	3358-3361	are	_	_	_	_
28-6	3362-3370	strongly	_	_	_	_
28-7	3371-3381	suppressed	_	_	_	_
28-8	3382-3388	during	_	_	_	_
28-9	3389-3395	normal	abstract[177]	giv[177]	_	_
28-10	3396-3400	cell	object|abstract[177]	giv|giv[177]	_	_
28-11	3401-3409	division	abstract[177]	giv[177]	_	_
28-12	3410-3411	,	_	_	_	_
28-13	3412-3416	they	object	giv	_	_
28-14	3417-3425	increase	_	_	_	_
28-15	3426-3431	after	_	_	_	_
28-16	3432-3461	replication-stress-associated	abstract[180]	new[180]	_	_
28-17	3462-3465	DSB	abstract|abstract[180]	new|new[180]	coref	41-12
28-18	3466-3478	accumulation	abstract[180]	new[180]	_	_
28-19	3479-3482	and	_	_	_	_
28-20	3483-3490	genomic	abstract[181]	giv[181]	coref	31-7[192_181]
28-21	3491-3506	destabilization	abstract[181]	giv[181]	_	_
28-22	3507-3508	.	_	_	_	_

#Text=Given that most cancers ultimately develop genomic instability , these mutations are most likely the ones that contribute to cancer progression .
29-1	3509-3514	Given	_	_	_	_
29-2	3515-3519	that	_	_	_	_
29-3	3520-3524	most	abstract[182]	new[182]	coref	33-12[205_182]
29-4	3525-3532	cancers	abstract[182]	new[182]	_	_
29-5	3533-3543	ultimately	_	_	_	_
29-6	3544-3551	develop	_	_	_	_
29-7	3552-3559	genomic	abstract[183]	giv[183]	coref	32-10[197_183]
29-8	3560-3571	instability	abstract[183]	giv[183]	_	_
29-9	3572-3573	,	_	_	_	_
29-10	3574-3579	these	abstract[184]	giv[184]	coref	45-13[254_184]
29-11	3580-3589	mutations	abstract[184]	giv[184]	_	_
29-12	3590-3593	are	_	_	_	_
29-13	3594-3598	most	_	_	_	_
29-14	3599-3605	likely	_	_	_	_
29-15	3606-3609	the	abstract[185]	new[185]	_	_
29-16	3610-3614	ones	abstract[185]	new[185]	_	_
29-17	3615-3619	that	_	_	_	_
29-18	3620-3630	contribute	_	_	_	_
29-19	3631-3633	to	_	_	_	_
29-20	3634-3640	cancer	abstract|abstract[187]	giv|new[187]	coref	32-2
29-21	3641-3652	progression	abstract[187]	new[187]	_	_
29-22	3653-3654	.	_	_	_	_

#Text=2.3 .
30-1	3655-3658	2.3	abstract	new	_	_
30-2	3659-3660	.	_	_	_	_

#Text=Senescence-Associated Increase in the Risk of Genomic Destabilization
31-1	3661-3682	Senescence-Associated	abstract[189]	new[189]	_	_
31-2	3683-3691	Increase	abstract[189]	new[189]	_	_
31-3	3692-3694	in	abstract[189]	new[189]	_	_
31-4	3695-3698	the	abstract[189]|abstract[190]	new[189]|giv[190]	coref	47-13[269_190]
31-5	3699-3703	Risk	abstract[189]|abstract[190]	new[189]|giv[190]	_	_
31-6	3704-3706	of	abstract[189]|abstract[190]	new[189]|giv[190]	_	_
31-7	3707-3714	Genomic	abstract[189]|abstract[190]|abstract|event[192]	new[189]|giv[190]|giv|giv[192]	coref	46-7[260_192]
31-8	3715-3730	Destabilization	abstract[189]|abstract[190]|event[192]	new[189]|giv[190]|giv[192]	_	_

#Text=Most cancer cells develop one of two forms of genomic instability : chromosomal instability ( CIN ) or microsatellite instability ( MSI ) .
32-1	3731-3735	Most	object[194]	giv[194]	coref	46-10[261_194]
32-2	3736-3742	cancer	abstract|object[194]	giv|giv[194]	coref	47-15
32-3	3743-3748	cells	object[194]	giv[194]	_	_
32-4	3749-3756	develop	_	_	_	_
32-5	3757-3760	one	abstract[195]	new[195]	_	_
32-6	3761-3763	of	abstract[195]	new[195]	_	_
32-7	3764-3767	two	abstract[195]|abstract[196]	new[195]|new[196]	appos	32-13[198_196]
32-8	3768-3773	forms	abstract[195]|abstract[196]	new[195]|new[196]	_	_
32-9	3774-3776	of	abstract[195]|abstract[196]	new[195]|new[196]	_	_
32-10	3777-3784	genomic	abstract[195]|abstract[196]|abstract[197]	new[195]|new[196]|giv[197]	coref	32-19[200_197]
32-11	3785-3796	instability	abstract[195]|abstract[196]|abstract[197]	new[195]|new[196]|giv[197]	_	_
32-12	3797-3798	:	_	_	_	_
32-13	3799-3810	chromosomal	abstract[198]	giv[198]	appos	32-16[0_198]
32-14	3811-3822	instability	abstract[198]	giv[198]	_	_
32-15	3823-3824	(	_	_	_	_
32-16	3825-3828	CIN	abstract	giv	coref	33-1
32-17	3829-3830	)	_	_	_	_
32-18	3831-3833	or	_	_	_	_
32-19	3834-3848	microsatellite	abstract[200]	giv[200]	appos	32-22[0_200]
32-20	3849-3860	instability	abstract[200]	giv[200]	_	_
32-21	3861-3862	(	_	_	_	_
32-22	3863-3866	MSI	abstract	giv	coref	33-8
32-23	3867-3868	)	_	_	_	_
32-24	3869-3870	.	_	_	_	_

#Text=CIN is the most frequent , but MSI usually arises in MMR-deficient cancers ( Table 1 ) .
33-1	3871-3874	CIN	abstract	giv	coref	37-1
33-2	3875-3877	is	_	_	_	_
33-3	3878-3881	the	_	_	_	_
33-4	3882-3886	most	_	_	_	_
33-5	3887-3895	frequent	_	_	_	_
33-6	3896-3897	,	_	_	_	_
33-7	3898-3901	but	_	_	_	_
33-8	3902-3905	MSI	abstract	giv	coref	34-7
33-9	3906-3913	usually	_	_	_	_
33-10	3914-3920	arises	_	_	_	_
33-11	3921-3923	in	_	_	_	_
33-12	3924-3937	MMR-deficient	object|abstract[205]	giv|giv[205]	coref	45-1[246_205]
33-13	3938-3945	cancers	abstract[205]	giv[205]	_	_
33-14	3946-3947	(	_	_	_	_
33-15	3948-3953	Table	object[206]	giv[206]	_	_
33-16	3954-3955	1	object[206]	giv[206]	_	_
33-17	3956-3957	)	_	_	_	_
33-18	3958-3959	.	_	_	_	_

#Text=The induction of both CIN and MSI is triggered by replication-stress-associated DSBs (
34-1	3960-3963	The	abstract[207]	giv[207]	_	_
34-2	3964-3973	induction	abstract[207]	giv[207]	_	_
34-3	3974-3976	of	abstract[207]	giv[207]	_	_
34-4	3977-3981	both	abstract[207]|abstract[208]	giv[207]|new[208]	coref	44-3[240_208]
34-5	3982-3985	CIN	abstract[207]|abstract[208]	giv[207]|new[208]	_	_
34-6	3986-3989	and	abstract[207]	giv[207]	_	_
34-7	3990-3993	MSI	abstract[207]|abstract	giv[207]|giv	coref	39-4
34-8	3994-3996	is	_	_	_	_
34-9	3997-4006	triggered	_	_	_	_
34-10	4007-4009	by	_	_	_	_
34-11	4010-4039	replication-stress-associated	abstract[210]	giv[210]	coref	37-18[0_210]
34-12	4040-4044	DSBs	abstract[210]	giv[210]	_	_
34-13	4045-4046	(	_	_	_	_

#Text=Figure 2
35-1	4047-4053	Figure	abstract[211]	new[211]	coref	42-1[239_211]
35-2	4054-4055	2	abstract[211]	new[211]	_	_

#Text=) .
36-1	4056-4057	)	_	_	_	_
36-2	4058-4059	.	_	_	_	_

#Text=CIN often occurs when such DSBs are not effectively repaired by HR , that is , when DSBs arising during replication are carried over into the following G1 phase at a time when HR is not functional .
37-1	4060-4063	CIN	abstract	giv	coref	41-5
37-2	4064-4069	often	_	_	_	_
37-3	4070-4076	occurs	_	_	_	_
37-4	4077-4081	when	_	_	_	_
37-5	4082-4086	such	abstract[213]	giv[213]	coref	44-10[242_213]
37-6	4087-4091	DSBs	abstract[213]	giv[213]	_	_
37-7	4092-4095	are	_	_	_	_
37-8	4096-4099	not	_	_	_	_
37-9	4100-4111	effectively	_	_	_	_
37-10	4112-4120	repaired	_	_	_	_
37-11	4121-4123	by	_	_	_	_
37-12	4124-4126	HR	abstract	giv	coref	37-34
37-13	4127-4128	,	_	_	_	_
37-14	4129-4133	that	_	_	_	_
37-15	4134-4136	is	_	_	_	_
37-16	4137-4138	,	_	_	_	_
37-17	4139-4143	when	_	_	_	_
37-18	4144-4148	DSBs	abstract	giv	coref	38-3[221_0]
37-19	4149-4156	arising	_	_	_	_
37-20	4157-4163	during	_	_	_	_
37-21	4164-4175	replication	abstract	giv	_	_
37-22	4176-4179	are	_	_	_	_
37-23	4180-4187	carried	_	_	_	_
37-24	4188-4192	over	_	_	_	_
37-25	4193-4197	into	_	_	_	_
37-26	4198-4201	the	time[218]	new[218]	_	_
37-27	4202-4211	following	time[218]	new[218]	_	_
37-28	4212-4214	G1	place|time[218]	new|new[218]	_	_
37-29	4215-4220	phase	time[218]	new[218]	_	_
37-30	4221-4223	at	_	_	_	_
37-31	4224-4225	a	time[219]	new[219]	_	_
37-32	4226-4230	time	time[219]	new[219]	_	_
37-33	4231-4235	when	_	_	_	_
37-34	4236-4238	HR	time	giv	_	_
37-35	4239-4241	is	_	_	_	_
37-36	4242-4245	not	_	_	_	_
37-37	4246-4256	functional	_	_	_	_
37-38	4257-4258	.	_	_	_	_

#Text=Consequently , the DSBs are often erroneously ligated by non-homologous end joining ( NHEJ ) with topologically incorrect broken ends , resulting in a background that causes CIN-associated chromosomal alterations such as chromosomal translocations , deletions , and rearrangements .
38-1	4259-4271	Consequently	_	_	_	_
38-2	4272-4273	,	_	_	_	_
38-3	4274-4277	the	abstract[221]	giv[221]	coref	39-7[232_221]
38-4	4278-4282	DSBs	abstract[221]	giv[221]	_	_
38-5	4283-4286	are	_	_	_	_
38-6	4287-4292	often	_	_	_	_
38-7	4293-4304	erroneously	_	_	_	_
38-8	4305-4312	ligated	_	_	_	_
38-9	4313-4315	by	_	_	_	_
38-10	4316-4330	non-homologous	event[222]	new[222]	coref	39-15[233_222]
38-11	4331-4334	end	event[222]	new[222]	_	_
38-12	4335-4342	joining	_	_	_	_
38-13	4343-4344	(	_	_	_	_
38-14	4345-4349	NHEJ	abstract	new	_	_
38-15	4350-4351	)	_	_	_	_
38-16	4352-4356	with	_	_	_	_
38-17	4357-4370	topologically	abstract[224]	new[224]	_	_
38-18	4371-4380	incorrect	abstract[224]	new[224]	_	_
38-19	4381-4387	broken	abstract[224]	new[224]	_	_
38-20	4388-4392	ends	abstract[224]	new[224]	_	_
38-21	4393-4394	,	_	_	_	_
38-22	4395-4404	resulting	_	_	_	_
38-23	4405-4407	in	_	_	_	_
38-24	4408-4409	a	abstract[225]	new[225]	coref	45-17[253_225]
38-25	4410-4420	background	abstract[225]	new[225]	_	_
38-26	4421-4425	that	_	_	_	_
38-27	4426-4432	causes	_	_	_	_
38-28	4433-4447	CIN-associated	abstract[227]	new[227]	_	_
38-29	4448-4459	chromosomal	place|abstract[227]	new|new[227]	_	_
38-30	4460-4471	alterations	abstract[227]	new[227]	_	_
38-31	4472-4476	such	abstract[227]	new[227]	_	_
38-32	4477-4479	as	abstract[227]	new[227]	_	_
38-33	4480-4491	chromosomal	abstract[227]|abstract[228]	new[227]|new[228]	_	_
38-34	4492-4506	translocations	abstract[227]|abstract[228]	new[227]|new[228]	_	_
38-35	4507-4508	,	abstract[227]	new[227]	_	_
38-36	4509-4518	deletions	abstract[227]|abstract	new[227]|giv	_	_
38-37	4519-4520	,	abstract[227]	new[227]	_	_
38-38	4521-4524	and	abstract[227]	new[227]	_	_
38-39	4525-4539	rearrangements	abstract[227]|event	new[227]|new	_	_
38-40	4540-4541	.	_	_	_	_

#Text=By contrast , MSI arises when those DSBs are effectively but erroneously repaired by microhomology-mediated end joining ( MMEJ ; also known as alternative end joining ) (
39-1	4542-4544	By	_	_	_	_
39-2	4545-4553	contrast	_	_	_	_
39-3	4554-4555	,	_	_	_	_
39-4	4556-4559	MSI	abstract	giv	coref	44-6
39-5	4560-4566	arises	_	_	_	_
39-6	4567-4571	when	_	_	_	_
39-7	4572-4577	those	abstract[232]	giv[232]	_	_
39-8	4578-4582	DSBs	abstract[232]	giv[232]	_	_
39-9	4583-4586	are	_	_	_	_
39-10	4587-4598	effectively	_	_	_	_
39-11	4599-4602	but	_	_	_	_
39-12	4603-4614	erroneously	_	_	_	_
39-13	4615-4623	repaired	_	_	_	_
39-14	4624-4626	by	_	_	_	_
39-15	4627-4649	microhomology-mediated	event[233]	giv[233]	_	_
39-16	4650-4653	end	event[233]	giv[233]	_	_
39-17	4654-4661	joining	_	_	_	_
39-18	4662-4663	(	_	_	_	_
39-19	4664-4668	MMEJ	object	new	_	_
39-20	4669-4670	;	_	_	_	_
39-21	4671-4675	also	_	_	_	_
39-22	4676-4681	known	_	_	_	_
39-23	4682-4684	as	_	_	_	_
39-24	4685-4696	alternative	_	_	_	_
39-25	4697-4700	end	_	_	_	_
39-26	4701-4708	joining	_	_	_	_
39-27	4709-4710	)	_	_	_	_
39-28	4711-4712	(	_	_	_	_

#Text=Figure 3
40-1	4713-4719	Figure	abstract[235]	new[235]	_	_
40-2	4720-4721	3	abstract[235]	new[235]	_	_

#Text=) , during which CIN is suppressed because of the resultant DSB repair (
41-1	4722-4723	)	_	_	_	_
41-2	4724-4725	,	_	_	_	_
41-3	4726-4732	during	_	_	_	_
41-4	4733-4738	which	_	_	_	_
41-5	4739-4742	CIN	abstract	giv	coref	45-4[248_0]
41-6	4743-4745	is	_	_	_	_
41-7	4746-4756	suppressed	_	_	_	_
41-8	4757-4764	because	_	_	_	_
41-9	4765-4767	of	_	_	_	_
41-10	4768-4771	the	abstract[238]	giv[238]	coref	44-18[244_238]
41-11	4772-4781	resultant	abstract[238]	giv[238]	_	_
41-12	4782-4785	DSB	abstract|abstract[238]	giv|giv[238]	coref	45-10
41-13	4786-4792	repair	abstract[238]	giv[238]	_	_
41-14	4793-4794	(	_	_	_	_

#Text=Figure 2
42-1	4795-4801	Figure	abstract[239]	giv[239]	_	_
42-2	4802-4803	2	abstract[239]	giv[239]	_	_

#Text=) .
43-1	4804-4805	)	_	_	_	_
43-2	4806-4807	.	_	_	_	_

#Text=Thus , both CIN and MSI are triggered by replication-stress-associated DSBs and arise due to abnormalities in the repair of these lesions .
44-1	4808-4812	Thus	_	_	_	_
44-2	4813-4814	,	_	_	_	_
44-3	4815-4819	both	abstract[240]	giv[240]	_	_
44-4	4820-4823	CIN	abstract[240]	giv[240]	_	_
44-5	4824-4827	and	_	_	_	_
44-6	4828-4831	MSI	abstract	giv	coref	45-4[247_0]
44-7	4832-4835	are	_	_	_	_
44-8	4836-4845	triggered	_	_	_	_
44-9	4846-4848	by	_	_	_	_
44-10	4849-4878	replication-stress-associated	abstract[242]	giv[242]	coref	48-3[270_242]
44-11	4879-4883	DSBs	abstract[242]	giv[242]	_	_
44-12	4884-4887	and	_	_	_	_
44-13	4888-4893	arise	_	_	_	_
44-14	4894-4897	due	_	_	_	_
44-15	4898-4900	to	_	_	_	_
44-16	4901-4914	abnormalities	abstract[243]	new[243]	coref	45-8[249_243]
44-17	4915-4917	in	abstract[243]	new[243]	_	_
44-18	4918-4921	the	abstract[243]|abstract[244]	new[243]|giv[244]	coref	45-10[251_244]
44-19	4922-4928	repair	abstract[243]|abstract[244]	new[243]|giv[244]	_	_
44-20	4929-4931	of	abstract[243]|abstract[244]	new[243]|giv[244]	_	_
44-21	4932-4937	these	abstract[243]|abstract[244]|abstract[245]	new[243]|giv[244]|new[245]	_	_
44-22	4938-4945	lesions	abstract[243]|abstract[244]|abstract[245]	new[243]|giv[244]|new[245]	_	_
44-23	4946-4947	.	_	_	_	_

#Text=Most cancers develop genomic instability due to abnormalities in DSB repair ; paradoxically , however , most lack background mutations in DNA repair systems .
45-1	4948-4952	Most	abstract[246]	giv[246]	_	_
45-2	4953-4960	cancers	abstract[246]	giv[246]	_	_
45-3	4961-4968	develop	_	_	_	_
45-4	4969-4976	genomic	abstract[247]|abstract[248]	giv[247]|giv[248]	_	_
45-5	4977-4988	instability	abstract[247]|abstract[248]	giv[247]|giv[248]	_	_
45-6	4989-4992	due	abstract[247]|abstract[248]	giv[247]|giv[248]	_	_
45-7	4993-4995	to	abstract[247]|abstract[248]	giv[247]|giv[248]	_	_
45-8	4996-5009	abnormalities	abstract[247]|abstract[248]|abstract[249]	giv[247]|giv[248]|giv[249]	_	_
45-9	5010-5012	in	abstract[247]|abstract[248]|abstract[249]	giv[247]|giv[248]|giv[249]	_	_
45-10	5013-5016	DSB	abstract[247]|abstract[248]|abstract[249]|abstract|abstract[251]	giv[247]|giv[248]|giv[249]|giv|giv[251]	coref|coref	45-23[0_251]|49-13
45-11	5017-5023	repair	abstract[247]|abstract[248]|abstract[249]|abstract[251]	giv[247]|giv[248]|giv[249]|giv[251]	_	_
45-12	5024-5025	;	abstract[248]	giv[248]	_	_
45-13	5026-5039	paradoxically	abstract[248]|abstract[254]	giv[248]|giv[254]	_	_
45-14	5040-5041	,	abstract[248]|abstract[254]	giv[248]|giv[254]	_	_
45-15	5042-5049	however	abstract[248]|abstract[254]	giv[248]|giv[254]	_	_
45-16	5050-5051	,	abstract[248]|abstract[254]	giv[248]|giv[254]	_	_
45-17	5052-5056	most	abstract[248]|abstract[252]|abstract[253]|abstract[254]	giv[248]|new[252]|giv[253]|giv[254]	_	_
45-18	5057-5061	lack	abstract[248]|abstract[252]|abstract[253]|abstract[254]	giv[248]|new[252]|giv[253]|giv[254]	_	_
45-19	5062-5072	background	abstract[248]|abstract[253]|abstract[254]	giv[248]|giv[253]|giv[254]	_	_
45-20	5073-5082	mutations	abstract[248]|abstract[254]	giv[248]|giv[254]	_	_
45-21	5083-5085	in	abstract[248]|abstract[254]	giv[248]|giv[254]	_	_
45-22	5086-5089	DNA	abstract[248]|abstract[254]|abstract|abstract[257]	giv[248]|giv[254]|giv|new[257]	coref|coref	46-23|46-22[265_257]
45-23	5090-5096	repair	abstract[248]|abstract[254]|abstract|abstract[257]	giv[248]|giv[254]|giv|new[257]	ana	46-1
45-24	5097-5104	systems	abstract[248]|abstract[254]|abstract[257]	giv[248]|giv[254]|new[257]	_	_
45-25	5105-5106	.	_	_	_	_

#Text=This raises the question of how genomic destabilization occurs even in normal cells , that is , genetically normal cells with functional DNA repair systems .
46-1	5107-5111	This	abstract	giv	coref	46-24
46-2	5112-5118	raises	_	_	_	_
46-3	5119-5122	the	abstract[259]	new[259]	_	_
46-4	5123-5131	question	abstract[259]	new[259]	_	_
46-5	5132-5134	of	abstract[259]	new[259]	_	_
46-6	5135-5138	how	abstract[259]	new[259]	_	_
46-7	5139-5146	genomic	event[260]	giv[260]	_	_
46-8	5147-5162	destabilization	event[260]	giv[260]	_	_
46-9	5163-5169	occurs	_	_	_	_
46-10	5170-5174	even	object[261]	giv[261]	coref	46-18[262_261]
46-11	5175-5177	in	object[261]	giv[261]	_	_
46-12	5178-5184	normal	object[261]	giv[261]	_	_
46-13	5185-5190	cells	object[261]	giv[261]	_	_
46-14	5191-5192	,	_	_	_	_
46-15	5193-5197	that	_	_	_	_
46-16	5198-5200	is	_	_	_	_
46-17	5201-5202	,	_	_	_	_
46-18	5203-5214	genetically	object[262]	giv[262]	coref	49-5[0_262]
46-19	5215-5221	normal	object[262]	giv[262]	_	_
46-20	5222-5227	cells	object[262]	giv[262]	_	_
46-21	5228-5232	with	object[262]	giv[262]	_	_
46-22	5233-5243	functional	object[262]|abstract[265]	giv[262]|giv[265]	_	_
46-23	5244-5247	DNA	object[262]|abstract|abstract[265]	giv[262]|giv|giv[265]	_	_
46-24	5248-5254	repair	object[262]|abstract|abstract[265]	giv[262]|giv|giv[265]	_	_
46-25	5255-5262	systems	object[262]|abstract[265]	giv[262]|giv[265]	_	_
46-26	5263-5264	.	_	_	_	_

#Text=This phenomenon is probably associated with age , which is associated with an elevated cancer risk .
47-1	5265-5269	This	abstract[266]	new[266]	_	_
47-2	5270-5280	phenomenon	abstract[266]	new[266]	_	_
47-3	5281-5283	is	_	_	_	_
47-4	5284-5292	probably	_	_	_	_
47-5	5293-5303	associated	_	_	_	_
47-6	5304-5308	with	_	_	_	_
47-7	5309-5312	age	abstract	new	coref	48-10[272_0]
47-8	5313-5314	,	_	_	_	_
47-9	5315-5320	which	_	_	_	_
47-10	5321-5323	is	_	_	_	_
47-11	5324-5334	associated	_	_	_	_
47-12	5335-5339	with	_	_	_	_
47-13	5340-5342	an	abstract[269]	giv[269]	_	_
47-14	5343-5351	elevated	abstract[269]	giv[269]	_	_
47-15	5352-5358	cancer	abstract|abstract[269]	giv|giv[269]	_	_
47-16	5359-5363	risk	abstract[269]	giv[269]	_	_
47-17	5364-5365	.	_	_	_	_

#Text=Indeed , irreparable DSBs accumulate widely in association with age in vivo and passage in vitro .
48-1	5366-5372	Indeed	_	_	_	_
48-2	5373-5374	,	_	_	_	_
48-3	5375-5386	irreparable	abstract[270]	giv[270]	_	_
48-4	5387-5391	DSBs	abstract[270]	giv[270]	_	_
48-5	5392-5402	accumulate	_	_	_	_
48-6	5403-5409	widely	_	_	_	_
48-7	5410-5412	in	_	_	_	_
48-8	5413-5424	association	abstract[271]	new[271]	_	_
48-9	5425-5429	with	abstract[271]	new[271]	_	_
48-10	5430-5433	age	abstract[271]|abstract[272]	new[271]|giv[272]	ana	49-3[0_272]
48-11	5434-5436	in	abstract[271]|abstract[272]	new[271]|giv[272]	_	_
48-12	5437-5441	vivo	abstract[271]|abstract[272]	new[271]|giv[272]	_	_
48-13	5442-5445	and	abstract[271]|abstract[272]	new[271]|giv[272]	_	_
48-14	5446-5453	passage	abstract[271]|abstract[272]|place[273]	new[271]|giv[272]|new[273]	_	_
48-15	5454-5456	in	abstract[271]|abstract[272]|place[273]	new[271]|giv[272]|new[273]	_	_
48-16	5457-5462	vitro	abstract[271]|abstract[272]|place[273]	new[271]|giv[272]|new[273]	_	_
48-17	5463-5464	.	_	_	_	_

#Text=Consistent with this , cells often undergo senescence as a consequence of DSB accumulation .
49-1	5465-5475	Consistent	_	_	_	_
49-2	5476-5480	with	_	_	_	_
49-3	5481-5485	this	abstract	giv	_	_
49-4	5486-5487	,	_	_	_	_
49-5	5488-5493	cells	object	giv	_	_
49-6	5494-5499	often	_	_	_	_
49-7	5500-5507	undergo	_	_	_	_
49-8	5508-5518	senescence	abstract	new	_	_
49-9	5519-5521	as	_	_	_	_
49-10	5522-5523	a	_	_	_	_
49-11	5524-5535	consequence	_	_	_	_
49-12	5536-5538	of	_	_	_	_
49-13	5539-5542	DSB	abstract|abstract[278]	giv|new[278]	coref|coref	50-5|50-5[281_278]
49-14	5543-5555	accumulation	abstract[278]	new[278]	_	_
49-15	5556-5557	.	_	_	_	_

#Text=Although the reasons for DSB accumulation are not clear , they are likely to include a reduction in histone H2AX , which mediates repair-factor recruitment and is required for genome stability .
50-1	5558-5566	Although	_	_	_	_
50-2	5567-5570	the	abstract[279]	new[279]	ana	50-11[0_279]
50-3	5571-5578	reasons	abstract[279]	new[279]	_	_
50-4	5579-5582	for	abstract[279]	new[279]	_	_
50-5	5583-5586	DSB	abstract[279]|abstract|abstract[281]	new[279]|giv|giv[281]	_	_
50-6	5587-5599	accumulation	abstract[279]|abstract[281]	new[279]|giv[281]	_	_
50-7	5600-5603	are	_	_	_	_
50-8	5604-5607	not	_	_	_	_
50-9	5608-5613	clear	_	_	_	_
50-10	5614-5615	,	_	_	_	_
50-11	5616-5620	they	abstract	giv	_	_
50-12	5621-5624	are	_	_	_	_
50-13	5625-5631	likely	_	_	_	_
50-14	5632-5634	to	_	_	_	_
50-15	5635-5642	include	_	_	_	_
50-16	5643-5644	a	abstract[283]	new[283]	_	_
50-17	5645-5654	reduction	abstract[283]	new[283]	_	_
50-18	5655-5657	in	abstract[283]	new[283]	_	_
50-19	5658-5665	histone	abstract[283]|substance|abstract[285]	new[283]|new|new[285]	_	_
50-20	5666-5670	H2AX	abstract[283]|abstract[285]	new[283]|new[285]	_	_
50-21	5671-5672	,	_	_	_	_
50-22	5673-5678	which	_	_	_	_
50-23	5679-5687	mediates	_	_	_	_
50-24	5688-5701	repair-factor	abstract[286]	new[286]	_	_
50-25	5702-5713	recruitment	abstract[286]	new[286]	_	_
50-26	5714-5717	and	_	_	_	_
50-27	5718-5720	is	_	_	_	_
50-28	5721-5729	required	_	_	_	_
50-29	5730-5733	for	_	_	_	_
50-30	5734-5740	genome	abstract|abstract[288]	new|new[288]	_	_
50-31	5741-5750	stability	abstract[288]	new[288]	_	_
50-32	5751-5752	.	_	_	_	_
